DCGI

The COVID-19 vaccine has been tested in adolescent population in the 12-18 years age group in India as well

The company has to submit seven days safety assessment of the vaccine in the first 100 beneficiaries before rolling out the…

If approved, it will be the world's first DNA vaccine against coronavirus and the fourth to become available in the country

Enrolment of patients has already begun at multiple sites across India and the trial is likely to be completed in the next 8-10…

The company informed that it will be commencing commercial production immediately after the approval is received

The firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology for developing Sputnik V at its…

By raising health awareness and putting in place well-defined regulations, consumers can be empowered to take proactive measures…

This formulation is available with 400 mg strength at a price of Rs 85 per tablet

MSN has launched the product under the brand name PosaOne as 100 mg Delayed-Release tablets and 300 mg injections, respectively

As per the clinical trial protocol approved, 2500 subjects with mild to moderate COVID-19 will be randomised in the study in a 1:1…